References
- Bottazzo G F. β cell damage in diabetic insulitis: are we approaching a solution?. Diabetologia 1984; 26: 24–249
- Srikanta S, Ganda O P, Eisenbarth G S, Soeldner J S. Islet cell antibodies and beta cell function in monozygotic triplets and twins initially discordant for Type I diabetes mellitus. N Eng J Med 1983; 308: 322–325
- Makino S, Kunimoto K, Muraoka T, Mizushima Y, Katagiri K, Tochino Y. Breeding of a non-obese diabetic strain of mice. Exp Anim 1980; 29: 1–13
- Harada H, Makino S. Immunologic analysis of the pathogenic mechanisms of diabetes in non-obese diabetes prone mice: obligatory role of T lymphocytes. 12th Congress of International Diabetes Federation, MadridSpain, 1985
- Koike T, Itoh Y, Ishi T, Ito I, Takabayashi K, Maruyama N, Tomioka H, Yoshida S. Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice. Diabetes 1987; 36: 539–541
- Wang Y, Hao L, Gill R. G., Lafferty K. J. Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent. Diabetes 1987; 36: 535–538
- Charlton B, Mandel T E. Progression from insulitis to β cell destruction in NOD mice requires L3T4+ cells. Diabetes 1988; 37: 1108–1113
- Shizuru J A, Taylor-Edwards C, Banks B A, Gregory A K, Fathman C G. Immunotherapy of the nonobese diabetic mouse: Treatment with an antibody to T-helper lymphocytes. Science 1988; 240: 659–662
- Benjamin R J, Waldmann H. Induction of tolerance by monoclonal antibody therapy. Nature 1986; 320: 449–451
- Pierres A, Naquet P, Van Agthoven A, Bekkhoucha F, Denizot F, Mishal Z, Schmitt-Verhulst A, Pierres M. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of la reactive T cell clones and delineates two phenotypically distinct (T4 +, Lyt-2,3 -, and T4-, Lyt-2,3 +) subsets among anti-la cytolytic T cell clones. J. Immunol 1984; 132: 2775–2782
- Charlton B, Burkhardt K, Mandel T E. How important is the L3T4 antigen to L3T4+ cell function in vivo?. Immunol Today 1988; 9: 165–167
- Janeway C A, Haque S, Smith L A, Saizawa K. The role of the murine L3T4 molecule in T cell activation: differential effects of anti-L3T4 on activation by monoclonal anti-receptor antibodies. J. Mol. Cell. Immunol. 1987; 3: 121–131
- Charlton B, Bacelj A, Slattery R M, Mandel T E. Cyclophosphamide induced diabetes in NOD/Wehi mice: evidence for suppression in autoimmune diabetes. Diabetes 1989, (in press)
- Swain S L. T cell subsets and the recognition of MHC class. Immunol. Rev. 1983; 74: 128–142
- Foulis A K, Farquharson M A. Aberrrant expression of HLA-DR antigens by insulin containing β cells in recent onset type I diabetes mellitus. Diabetes 1986; 35: 1215–1224
- Dean B M, Walker R, Bone A J, Baird J D, Cooke A. Pre-diabetic BB/E rat: lymphocyte subpopulations in the pancreatic infiltrate and expression of rat MHC class II molecules in endocrine cells. Diabetologia 1985; 28: 464–466
- Bottazzo G F, Pujol-Borrell R, Hanafusa T, Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in indication of endocrine autoimmunity. Lancet 1983; 2: 1115–1118
- Qin S, Cobbold S, Tighe H, Benjimin R, Waldmann H. CD4 monoclonal antibody pairs for immunosuppression and tolerance induction. Eur. J. immunol. 1987; 17: 1159–1165
- Charlton B, Mandel T E. Tolerance to aggregated human IgG but not ovalbumin can be induced by concurrent administration of either depleting or non-depleting anti-L3T4 monoclonal antibodies. Immunol. Cell Biol 1989, (in press)
- Goronzy J, Weyand C M, Fathman C G. Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4. J. Exp. Med. 1986; 164: 911–925
- Reddy S, Bibby N J, Elliot R B. Ontogeny of islet cell antibodies, insulin autoantibodies and insulitis. Diabetologia 1988; 31: 322–327